EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications

Jordyn Kettner iD, Elizabeth Donnelly iD, Marina L Maes iD

Journal of Pharmacy Practice · 2026-06 · 39 (3) · 239-250

DOI: 10.1177/08971900251376795 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmacy Practice, online erschienen am 04.09.2025. Verfasst von Jordyn Kettner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ambulatory Care Clinical Pharmacist, University of Wisconsin Health, Middleton, WI, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Reproductive Health, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have experienced rapid growth in recent years as treatments for type 2 diabetes mellitus and obesity. These medications offer promising benefits, including weight loss and improved glycemic control; however, their implications for reproductive health warrant attention. While tirzepatide has been shown to impact absorption of oral contraceptives due to delayed gastric emptying, other GLP-1RAs do not appear to have clinically significant interactions with oral contraception. Fertility outcomes may improve with GLP-1RAs and dual GLP-1/GIP agonists due to weight loss and related metabolic benefits. Despite their widespread use, data on GLP-1RAs in pregnancy and lactation remain limited, leaving significant gaps in guidance for clinicians. This review synthesizes current literature on GLP-1RAs to highlight reproductive health considerations, including their potential impacts on contraception, fertility, pregnancy, and lactation. Greater awareness and understanding of these factors can support informed decision-making and optimize care for individuals using GLP-1RAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsReproductive HealthHypoglycemic AgentsHumansPregnancyFemaleDiabetes Mellitus, Type 2LactationObesity

Stichwörter der Autor:innen

contraceptionfertilityglucagon-like peptide-1 receptor agonistpregnancy lactationreproductive health

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Autor:innen und Institutionen

  • Ambulatory Care Clinical Pharmacist, University of Wisconsin Health, Middleton, WI, USA.
  • PGY2 Ambulatory Care Clinical Pharmacist, William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.
  • Pharmacy Practice and Translational Research Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.

ORCID-Profile: Jordyn Kettner, Elizabeth Donnelly, Marina L Maes

Zitieren

APA

Kettner, J., Donnelly, E., & Maes, M. L. (2026). Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications. Journal of Pharmacy Practice, 39(3), 239-250. https://doi.org/10.1177/08971900251376795

Vancouver

Kettner J, Donnelly E, Maes ML. Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications. Journal of Pharmacy Practice. 2026;39(3):239-250. doi:10.1177/08971900251376795

BibTeX
@article{Kettner2026,
  author = {Kettner, Jordyn and Donnelly, Elizabeth and Maes, Marina L},
  title = {Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications},
  journal = {Journal of Pharmacy Practice},
  year = {2026},
  volume = {39},
  number = {3},
  pages = {239--250},
  doi = {10.1177/08971900251376795}
}
Kostenlos starten →